Evgen Pharma plc (LON: EVG), the clinical stage drug development company focused on cancer and neurological conditions, announced today its unaudited interim results for the six..
Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announced today that a trials-in-progress poster..
Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, have announced today that Steve Franklin,..
Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces the appointment with immediate effect..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that it has raised..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, is today holding an Investor Symposium for..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, have announced today that it is to..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will hold its Annual General Meeting later..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announced today that it has concluded patient..
Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to..
Evgen Pharma PLC (LON:EVG) Chief Executive Officer Dr Stephen Franklin caught up with DirectorsTalk for an exclusive interview to discuss the interim update on their STEM..
Evgen Pharma Plc (LON:EVG) CEO Dr Stephen Franklin talks to DirectorsTalk about its Interim update on STEM trial. Stephen reminds us what the STEM trial is,..
Evgen Pharma plc (LON:EVG), the clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces its final results for the year..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced an encouraging interim update..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced the following update on..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that the results of..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced a collaboration with King’s..
Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to..
Evgen Pharma Plc (LON:EVG) is the topic of conversation when Vadim Alexandre, Head of Research at Northland Capital Partners joins DirectorsTalk. With Evgen proving it’s interim..
Evgen Pharma plc (LON:EVG), the clinical stage drug development company focused on cancer and neurological conditions, announces its unaudited interim results for the six months ended..
